Table 1.
Clinical markers, symptoms and quality of life
| Control period (no fiber added) | Intervention period with added fiber | P value | |
|---|---|---|---|
| Weight (kg) |
89 ± 6 |
90 ± 6 |
NS |
|
Clinical markers |
|
|
|
| Glucose mg/dL |
136 ± 29 |
146 ± 25 |
NS |
| LDL mg/dL |
100 ± 8 |
93 ± 7 |
P = 0.05 |
| HDL mg/dL |
47 ± 4 |
47 ± 4 |
NS |
| Total CHOL mg/dL |
175 ± 12 |
167 ± 11 |
P = 0.02 |
| TG mg/dL |
165 ± 21 |
154 ± 21 |
NS |
| CHOL:HDL ratio |
4.0 ± 0.3 |
3.7 ± 0.2 |
P = 0.02 |
|
KDQOL-36™ |
|
|
|
| Symptom/Problem list |
78 ± 3 |
80 ± 3 |
NS |
| Effects of kidney disease |
84 ± 4 |
87 ± 3 |
NS |
| Burden of kidney disease |
67 ± 6 |
73 ± 6 |
NS |
| Physical component summary |
31 ± 2 |
35 ± 3 |
P = 0.02 |
| Mental component summary |
53 ± 2 |
48 ± 2 |
P = 0.01 |
| Overall mean scores |
63 ± 3 |
64 ± 3 |
NS |
|
Symptoms |
|
|
|
| SNAQ |
14 ± 1 |
14 ± 1 |
NS |
| GSRS |
23 ± 1 |
22 ± 1 |
NS |
| ESS |
10 ± 1 |
8 ± 1 |
P = 0.04 |
| Stool frequency | 1.3 ± 0.2 | 1.6 ± 0.2 | P = 0.02 |
Data are means ± SE. Values are compared using paired t-test and significance is determined at P < 0.05.